MedTrace Logo

Prevention of Recurrent Preterm Delivery by a Natural Progesterone Agent

NCT00329316 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2008-06-27

No results posted yet for this study

Summary

To examine the preterm delivery rate of a preterm delivery high risk group of pregnant women, using once daily natural progesterone agent.

Conditions

  • Pregnancy
  • Premature Birth

Interventions

DRUG

Crinone Gel 8%

Sponsors & Collaborators

  • The Baruch Padeh Medical Center, Poriya

    lead OTHER_GOV

Principal Investigators

  • Yuri Perlitz, MD · The Baruch Padeh Medical Center, Poriya

  • Mosheh Ben Ami, Prof. · Head of Obs/Gyn ,The Baruch Padeh Medical center, Poriya

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00329316 on ClinicalTrials.gov